Company Overview and News

 
Syndicated Metals posts maiden JORC resource for Korong gold deposit in WA

2018-09-10 proactiveinvestors.com.au
Syndicated Metals Ltd (ASX:SMD) has estimated a maiden JORC-compliant gold mineral resource of 50,000 ounces for the Korong deposit within its Monument project near Laverton in WA.
SMD DCN

1
Kin appoints new CEO

2018-04-27 businessnews.com.au
Aspiring gold miner KIN Mining has appointed former Syndicated Metals managing director Andrew Munckton as its new chief executive after former leader Don Harper quit in February.
SMD KIN

4
Kin Mining appoints experienced Andrew Munckton as chief executive officer

2018-04-27 proactiveinvestors.com.au
As a geologist and holder of numerous executive roles with a wide range of mining companies, Munckton will be valuable in shaping the group’s strategy.
GDBGF SMD GBG NST NHRNY KIN NESRF AVI

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to ASX:SMD / SYNDICATED METALS LIMITED on message board site Silicon Investor.

Sirenza Microdevices Inc (SMDI) Sirenza Microdevices Inc (SMDI) Sirenza Microdevices Inc (SMDI) Fibroids in Women (BSMD) Fibroids in Women (BSMD) Fibroids in Women (BSMD)
BSMD: BioSphere Medical, Inc. BSMD: BioSphere Medical, Inc. BSMD: BioSphere Medical, Inc. SMDX Spectrumedix SMDX Spectrumedix SMDX Spectrumedix
SMDI -- About Stanford Microdevices, Inc. SMDI -- About Stanford Microdevices, Inc. SMDI -- About Stanford Microdevices, Inc. SmartDisk Corporation-(SMDK) SmartDisk Corporation-(SMDK) SmartDisk Corporation-(SMDK)
BSMD-Biosphere BSMD-Biosphere BSMD-Biosphere Sunrise Medical (SMD) Sunrise Medical (SMD) Sunrise Medical (SMD)
Sterlingmarc Mining Ltd. Sterlingmarc Mining Ltd. Sterlingmarc Mining Ltd.